IRIS
SPAGNUOLO, ROCCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.095
AS - Asia 1.691
EU - Europa 1.360
SA - Sud America 423
Continente sconosciuto - Info sul continente non disponibili 176
OC - Oceania 47
AF - Africa 46
Totale 6.838
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.964
SG - Singapore 729
IT - Italia 622
CN - Cina 325
BR - Brasile 317
DE - Germania 232
VN - Vietnam 217
GB - Regno Unito 143
IN - India 138
FI - Finlandia 110
CA - Canada 82
HK - Hong Kong 59
NL - Olanda 52
SE - Svezia 50
AR - Argentina 40
AU - Australia 39
BD - Bangladesh 25
MX - Messico 23
ID - Indonesia 22
IR - Iran 22
FR - Francia 20
EC - Ecuador 19
IQ - Iraq 18
KH - Cambogia 18
PL - Polonia 17
RO - Romania 15
MY - Malesia 13
RU - Federazione Russa 13
TR - Turchia 13
CL - Cile 12
CO - Colombia 12
ES - Italia 12
JP - Giappone 12
AT - Austria 11
TH - Thailandia 11
PK - Pakistan 10
KR - Corea 8
NZ - Nuova Zelanda 8
ZA - Sudafrica 8
ET - Etiopia 7
IE - Irlanda 7
UA - Ucraina 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
LV - Lettonia 6
MA - Marocco 6
PH - Filippine 6
PY - Paraguay 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
EG - Egitto 5
GR - Grecia 5
JM - Giamaica 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
YE - Yemen 5
DK - Danimarca 4
DZ - Algeria 4
LT - Lituania 4
NP - Nepal 4
TN - Tunisia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
CY - Cipro 3
DO - Repubblica Dominicana 3
HR - Croazia 3
LB - Libano 3
PE - Perù 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
BY - Bielorussia 2
CR - Costa Rica 2
CU - Cuba 2
EU - Europa 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
PT - Portogallo 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BM - Bermuda 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
Totale 6.658
Salva come PNG Salva come JPEG
Città #
San Jose 514
Ashburn 334
Singapore 301
Chandler 191
Dallas 185
Munich 176
Santa Clara 132
Council Bluffs 118
Milan 102
Ho Chi Minh City 96
Bengaluru 94
Hefei 91
New York 80
Los Angeles 79
Chicago 78
Beijing 65
London 64
Helsinki 61
Catanzaro 60
Phoenix 60
Hong Kong 55
Princeton 51
Lawrence 50
Turku 41
Boardman 40
São Paulo 39
San Francisco 37
Hanoi 35
Rome 33
Wilmington 24
Denver 23
Edinburgh 22
Montreal 21
Orem 20
Phnom Penh 18
Brooklyn 17
Des Moines 16
Rio de Janeiro 16
Toronto 15
Sydney 14
Boston 13
Amsterdam 12
Atlanta 12
Mexico City 11
Palermo 11
Redwood City 11
Buffalo 10
Chennai 10
Hamilton 10
Nuremberg 10
Redmond 10
Tokyo 10
Turin 10
Warsaw 10
Bari 9
Houston 9
Naples 9
Biên Hòa 8
Christchurch 8
Florence 8
Guayaquil 8
Miami 8
San Nicola Manfredi 8
Shanghai 8
Taranto 8
Adelaide 7
Belo Horizonte 7
Brisbane 7
Campinas 7
Da Nang 7
Fortaleza 7
Guangzhou 7
Hanover 7
Hải Dương 7
Kingston 7
Mumbai 7
Ottawa 7
Seattle 7
Washington 7
Athens 6
Brasília 6
Campo Bom 6
Hortolândia 6
Jakarta 6
Norwalk 6
Pattaya 6
Perth 6
Riga 6
Verona 6
Bắc Giang 5
Catania 5
Collegeville 5
Columbus 5
Curitiba 5
Delhi 5
Dhaka 5
Dublin 5
Goiânia 5
Horia 5
Jyväskylä 5
Totale 3.922
Salva come PNG Salva come JPEG
Nome #
BETA-GLUCAN, INOSITOL AND DIGESTIVE ENZYMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH IRRITABLE BOWEL SYNDROME 640
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 316
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 263
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells. 150
COMPARISON BETWEEN DIFFERENT BOWEL PREPARATION REGIMENS FOR COLONOSCOPY: A SINGLE-CENTRE STUDY 90
Anti interleukin 12/23 in the treatment of erythema nodosum and Crohn disease: A case report. 85
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 84
COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment 83
Acceptability of endoscopic procedures and patients' willingness to repeat them: a single-centre nursing study of influential factors 83
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report 83
Patient Reported Outcomes come strumento infermieristico nella gestione delle Malattie Infiammatorie Croniche Intestinali (MICI): Sintomi Gastrointestinali e Alterazioni Psicosociali. 82
DIAPHRAGMATIC REHABILITATION IN GASTROOESOPHAGEAL REFLUX DISEASE 82
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update 80
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 80
Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study 79
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 78
Effects of a Portfolio-Mediterranean Diet and a Mediterranean Diet with or without a Sterol-Enriched Yogurt in Individuals with Hypercholesterolemia 78
The role of gluten-free diet in nonalcoholic fatty liver disease development 78
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 77
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 75
L’epatopatia alcolica: dal danno alla terapia 72
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 71
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 71
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 70
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 70
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 69
OUTCOME OF ARTHRALGIA IN A SUBGROUP OF INFLAMMATORY BOWEL DISEASE PATIENTS WITH ANTI-TNF-ALPHA. A SINGLE CENTRE STUDY 68
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus 67
Impact of Nursing Interventions via Telephone and Email on the Quality of Life of Patients with Inflammatory Bowel Disease: Preliminary Results of a Comparative Observational Study 67
Exome-wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated with Fatty Liver Disease 67
Nursing-sensitive outcomes in adult inflammatory bowel disease: A systematic review 67
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study 66
Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: Results from a multicenter randomized double-blind placebo-controlled gluten challenge 66
Deregulation of SGK1 in Ulcerative Colitis: a paradoxical relationship between immune cells and colonic epithelial cells 65
Psychometric evaluation of an Italian custom 4-item short form of the PROMIS anxiety item bank in immune-mediated inflammatory diseases: An item response theory analysis 64
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies 62
Nursing communication as a tool for patient satisfaction. A single hospital survey 62
Nursing issues in enteral nutrition during prone position in critically ill patients: A systematic review of the literature 62
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 61
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 61
C-reactive protein induces tissue factor expression and promotes smooth muscle cells and endothelial cell proliferation 61
Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases 61
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 60
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 60
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay 60
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 59
OBSERVING THE INFLUENCE OF SHAME AND GUILT IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW 58
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 58
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 58
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes. 58
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 58
W1173 An In Vivo Study to Evaluate {MLCK} Expression in Patients with Inflammatory Bowel Diseases 57
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 57
The role of Neopterin in cardiovascular disease 57
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 57
The effects of stress on gut virome: Implications on infectious disease and systemic disorders 56
Visualization of Comorbidities in Inflammatory Bowel Diseases through Networks 56
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 55
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. 55
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 55
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 54
Lived Experiences of Patients With Inflammatory Bowel Disease in Italy: A Phenomenological Investigation 54
Alagille Syndrome and Its Clinical and Laboratory Features: A Case Report 53
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study 53
Pyoderma Gangrenosum and inflammatory bowel disease: a combined medical and surgical approach - case report and literature review 53
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 53
Effect of excess body weight on the genetic susceptibility to cancer. 51
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 51
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE study 50
Surgery for a gastric Dieulafoy's lesion reveals an occult bleeding jejunal diverticulum. A case report. 50
HIGH DIAGNOSTIC YIELD OF HISTOLOGICAL ANALYSIS OF EUS FINE-NEEDLE ASPIRATION BIOPSY INCLUDED IN FORMALIN WITHOUT ON-SITE CYTOPATHOLOGIC EXAMINATION. A RETROSPECTIVE STUDY 49
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 49
Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era 48
Pro-atherothrombotic effects of sigarette smoking in endothelial cells. Protective effects of statins 47
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 46
Can dysmetabolic comorbidities carry hepatic fat accumulation in patients with inflammatory bowel diseases? 46
Esophageal rupture after Heimlich maneuver: a case report and literature review 44
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study 44
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study 43
Use of biosimilars in inflammatory bowel disease: A position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 43
Milk thistle, Sylibum marianum 42
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 42
MBOAT7 in liver and extrahepatic diseases 41
Milk Thistle, Silybum marianum 40
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study 38
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 37
Gastrointestinal symptoms of and psychosocial changes in inflammatory bowel disease: A nursing-led cross-sectional study of patients in clinical remission 37
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 34
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 32
Cross talk between liver and adipose tissue: A new role for PNPLA3? 32
Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic Features 29
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 28
Functional disorders of the upper digestive tract: epidemiological, clinical and therapeutic aspects 27
A Case of a Neuroendocrine Tumor in a Liver Transplant Patient: Diagnostic and Management Difficulties 27
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study 26
Current management of acute severe ulcerative colitis in Italy: Results from an IG-IBD survey 24
Th17/treg balance in Inflammatory Bowel Disease: the role of microbial, and genetic regulators in disease modulation 23
Interleukin 23: Pathogenetic Involvement and Therapeutic Target for Ulcerative Colitis 22
Impact of Endoscopic Band Ligation on Gastric Complications Associated with Portal Hypertension 21
107 Results From the {\textquotedblleft}{GLUTOX}{\textquotedblright} Trial: A Randomised, Double Blind, Placebo Controlled Crossover Study on {\textquotedblleft}Non Celiac Gluten Sensitivity{\textquotedblright} 21
Totale 6.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.252
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022194 0 0 0 41 16 8 9 39 15 35 22 9
2022/2023672 104 52 23 64 56 47 19 73 86 47 64 37
2023/2024552 94 68 49 32 41 94 25 44 22 14 15 54
2024/20251.288 139 41 39 44 94 148 127 77 158 41 144 236
2025/20263.123 168 276 309 414 280 134 365 170 291 194 454 68
2026/2027740 65 207 310 158 0 0 0 0 0 0 0 0
Totale 6.838